Christopher Gibson - 11 Mar 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Nathan Hatfield, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
11 Mar 2022
Net transactions value
-$2,176,801
Form type
4
Filing time
15 Mar 2022, 20:57:24 UTC
Previous filing
09 Mar 2022
Next filing
07 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Conversion of derivative security $0 +100,000 +43% $0.000000 334,020 11 Mar 2022 Direct F1, F2
transaction RXRX Class A Common Stock Sale $694,580 -100,000 -30% $6.95 234,020 11 Mar 2022 Direct F3, F4
transaction RXRX Class A Common Stock Conversion of derivative security $0 +230,000 +98% $0.000000 464,020 14 Mar 2022 Direct F1, F2
transaction RXRX Class A Common Stock Sale $1,444,814 -230,000 -50% $6.28 234,020 14 Mar 2022 Direct F3, F5
transaction RXRX Class A Common Stock Conversion of derivative security $0 +6,150 +2.6% $0.000000 240,170 15 Mar 2022 Direct F1, F2
transaction RXRX Class A Common Stock Sale $37,407 -6,150 -2.6% $6.08 234,020 15 Mar 2022 Direct F3, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -100,000 -1.4% $0.000000 7,258,484 11 Mar 2022 Class A Common Stock 7,258,484 $0.000000 Direct F1, F2
transaction RXRX Class B Common Stock Conversion of derivative security $0 -230,000 -3.2% $0.000000 7,028,484 14 Mar 2022 Class A Common Stock 7,028,484 $0.000000 Direct F1, F2
transaction RXRX Class B Common Stock Conversion of derivative security $0 -6,150 -0.09% $0.000000 7,022,334 15 Mar 2022 Class A Common Stock 7,022,334 $0.000000 Direct F1, F2
holding RXRX Stock Option (Right to Buy) 416,350 11 Mar 2022 Class A Common Stock 416,350 $11.40 Direct F7
holding RXRX Stock Option (Right to Buy) 5,436 11 Mar 2022 Class A Common Stock 5,436 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 1,471,354 11 Mar 2022 Class A Common Stock 1,471,354 $2.47 Direct F8
holding RXRX Class B Common Stock 550,000 11 Mar 2022 Class A Common Stock 550,000 $0.000000 by LAHWRAN-3 LLC F2, F9
holding RXRX Class B Common Stock 550,000 11 Mar 2022 Class A Common Stock 550,000 $0.000000 by LAHWRAN-4 LLC F2, F10
holding RXRX Class B Common Stock 146,875 11 Mar 2022 Class A Common Stock 146,875 $0.000000 by Gibson Family Trust F2, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion of Class B Common Stock into Class A Common Stock.
F2 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F3 Shares were sold by a lender to the Reporting Person to satisfy a margin call related to a loan in which the shares served as collateral. As of March 15, 2022, Reporting Person has fully repaid the loan and no shares of the Company are currently serving as collateral for such loan.
F4 This transaction was executed in multiple trades at prices ranging from $6.72 to $7.42. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $6.065 to $6.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price
F6 This transaction was executed in multiple trades at prices ranging from $5.83 to $6.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price
F7 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F8 The option, originally for 1,500,000 shares, of which 28,646 shares have been exercised, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F9 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F10 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F11 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.